GlaxoSmithKline Pharmaceuticals Limited
GLAXO
Quarterly results
Revenue and net profit
₹ crore
Drag across a chart to read any period; every figure is listed under it. Tap the name of a metric for its year-on-year change.
- Income
- ₹ crore
Sept 20261,180
Quarter ₹ crore YoY Sept 2024 1,000 +4.9% Dec 2024 946 +17.6% Mar 2025 966 +6.1% Jun 2025 805 -0.8% Sept 2025 974 -2.6% Dec 2025 1,023 +8.1% Mar 2026 989 +2.4% Jun 2026 924 +14.9% Sept 2026 1,180 +21.2% - ₹ crore
Sept 202673
Quarter ₹ crore Sept 2024 32 Dec 2024 35 Mar 2025 39 Jun 2025 44 Sept 2025 31 Dec 2025 32 Mar 2026 36 Jun 2026 62 Sept 2026 73 - ₹ crore
Sept 20261,253
Quarter ₹ crore Sept 2024 1,032 Dec 2024 981 Mar 2025 1,006 Jun 2025 849 Sept 2025 1,005 Dec 2025 1,054 Mar 2026 1,025 Jun 2026 986 Sept 2026 1,253 - Cost structure
- ₹ crore
Sept 2026170
Quarter ₹ crore Sept 2024 151 Dec 2024 125 Mar 2025 153 Jun 2025 153 Sept 2025 138 Dec 2025 152 Mar 2026 165 Jun 2026 159 Sept 2026 170 - ₹ crore
Sept 2026795
Quarter ₹ crore Sept 2024 698 Dec 2024 675 Mar 2025 651 Jun 2025 570 Sept 2025 657 Dec 2025 677 Mar 2026 656 Jun 2026 648 Sept 2026 795 - Exceptional items and tax
- ₹ crore
Sept 2026458
Quarter ₹ crore Sept 2024 339 Dec 2024 306 Mar 2025 355 Jun 2025 279 Sept 2025 351 Dec 2025 378 Mar 2026 369 Jun 2026 338 Sept 2026 458 - ₹ crore
Sept 2026123
Quarter ₹ crore Sept 2024 90 Dec 2024 78 Mar 2025 95 Jun 2025 74 Sept 2025 96 Dec 2025 101 Mar 2026 94 Jun 2026 85 Sept 2026 123 - Profit
- ₹ crore
Sept 2026335
Quarter ₹ crore YoY Sept 2024 249 +15.4% Dec 2024 229 +402.5% Mar 2025 260 +34.7% Jun 2025 205 +12.7% Sept 2025 255 +2.5% Dec 2025 277 +21.3% Mar 2026 275 +5.7% Jun 2026 253 +23.8% Sept 2026 335 +31.2% - Per share
- ₹ per share
Sept 202619.76
Quarter ₹ per share Sept 2024 14.45 Dec 2024 13.49 Mar 2025 15.35 Jun 2025 12.08 Sept 2025 14.92 Dec 2025 16.36 Mar 2026 16.23 Jun 2026 14.95 Sept 2026 19.76 - Leverage
Debt to equity
timesMar 20260.00x
Quarter times Sept 2024 — Dec 2024 — Mar 2025 0.00x Jun 2025 — Sept 2025 — Dec 2025 — Mar 2026 0.00x Jun 2026 — Sept 2026 —
| ₹ crore | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sept 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Income | |||||||||
| 1,000 | 946 | 966 | 805 | 974 | 1,023 | 989 | 924 | 1,180 | |
| Revenue YoY | +4.9% | +17.6% | +6.1% | -0.8% | -2.6% | +8.1% | +2.4% | +14.9% | +21.2% |
| 32 | 35 | 39 | 44 | 31 | 32 | 36 | 62 | 73 | |
| 1,032 | 981 | 1,006 | 849 | 1,005 | 1,054 | 1,025 | 986 | 1,253 | |
| Cost structure | |||||||||
| 151 | 125 | 153 | 153 | 138 | 152 | 165 | 159 | 170 | |
| 698 | 675 | 651 | 570 | 657 | 677 | 656 | 648 | 795 | |
| Exceptional items and tax | |||||||||
| 339 | 306 | 355 | 279 | 351 | 378 | 369 | 338 | 458 | |
| 90 | 78 | 95 | 74 | 96 | 101 | 94 | 85 | 123 | |
| Profit | |||||||||
| 249 | 229 | 260 | 205 | 255 | 277 | 275 | 253 | 335 | |
| Net profit YoY | +15.4% | +402.5% | +34.7% | +12.7% | +2.5% | +21.3% | +5.7% | +23.8% | +31.2% |
| Per share | |||||||||
| 14.45 | 13.49 | 15.35 | 12.08 | 14.92 | 16.36 | 16.23 | 14.95 | 19.76 | |
| Leverage | |||||||||
| Debt to equity | — | — | 0.00x | — | — | — | 0.00x | — | — |
Latest filed period ends Sept 2026. Figures are in ₹ crore except rows named with a %, which are percentages, and EPS, which is rupees per share. An asterisk on a YoY figure means the prior period was a loss, so the percentage is computed on its absolute value. Click an underlined row name for its year-on-year change, against the same period a year earlier — blank where that period was not filed, or, on rows other than revenue and net profit, where it is not one of the 9 shown. Every blank change says which of the two it is when you rest on the dash, so a gap in the oldest columns need not be read as no growth. Rows that are already a ratio carry no change: a move from 2.00% to 2.24% is 24 basis points, not a percentage.